Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-08

Clinical Trial Update: Dexamethasone Dose for Postoperative Nausea and Vomiting Prophylaxis in Obese Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating dexamethasone dose for preventing postoperative nausea and vomiting in obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Diskapi Yildirim Beyazit Education and Research Hospital | Conditions: Postoperative Nausea and Vomiting | Phase 4 | Status: UNKNOWN